Who are Gain Therapeutics, Inc.'s main suppliers?

Gain Therapeutics, Inc. (GANX) key suppliers include: MINORYX-THERAPEUTICS-SL. View the full supplier network at chainsifter.com/chain/GANX.

What sector is Gain Therapeutics, Inc. in?

Gain Therapeutics, Inc. (GANX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

GANX Supply Chain: Gain Therapeutics, Inc. Suppliers & Customers

1Suppliers

0Customers

2Debt Items

4Related Chains

Gain Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
MINORYX-THERAPEUTICS-SL	MINORYX-THERAPEUTICS-SL	92%	In December 2017, the Company entered into an exclusive worldwide, royalty-bearing, assignable, transferable license agreement with Minoryx to use and exploit Minoryx’s intellectual property

Gain Therapeutics, Inc. Customers

No clients on recordNo downstream customers found in our database for Gain Therapeutics, Inc..

Gain Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
GANX-DEBT	Debt stack $672,302	90%	Market cache reports total debt of $672,302.
GANX-DEBT-9714	Warrants outstanding: 200000	90%	xbrl warrant detail from xbrl 2025-12-31.

Gain Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Gain Therapeutics, Inc..

Gain Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
GANX-OWNER-MARSHALL-WACE-LLP	MARSHALL WACE, LLP	90%	13F overlay lists MARSHALL WACE, LLP as top holder; 43 tracked holders.

Gain Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
HTGC	Hercules Capital, Inc.	100.00	2
LLY	Eli Lilly and Company	100.00	2
VYGR	Voyager Therapeutics, Inc.	100.00	2
ALEC	Alector, Inc.	36.29	1	['spend']

Gain Therapeutics, Inc. Supply Chain